Jump to Navigation
Home
News
Daily News
Documents
Health Insider
Abortion Roundup
Special Opioid Report
Topics
Biden Health Agenda
Election 2024
AI
Coronavirus
Abortion
Health Equity
Health Reform Debate
Opioids
Medicaid
Medicare
Rx Drugs
Medical Devices
Congress
ACOs
Emergency Response
The Courts
21st Century Cures
Budget
Cybersecurity
Food Safety
Tobacco
User Fees
Waste and Fraud
FDA Week
Inside CMS
Inside Drug Pricing
Latest News
Documents
Health Exchange Alert
Latest News
Documents
Inside TeleHealth
About Us
About Us
Privacy Policy
Terms and Conditions
Login Help
Wednesday, May 15, 2024
Dr. Reddy's Receives FDA Letter On AmVazTM
Pfizer Statement On FDA Decision To Reevaluate Dr. Reddy's NDA
/index.php?option=com_iwpfile&file=/dir_04/he2004_0271.pdf
FDA Announces Rule To Ban Ephedra
FDA Ephedra Rule
CSPI Response To Ephedra Ban
Waxman Responds To Ephedra Ban
/index.php?option=com_iwpfile&file=/dir_04/he2004_0269.pdf
Stark Press Release
Stark Report
/index.php?option=com_iwpfile&file=/dir_04/he2004_0267.pdf
/index.php?option=com_iwpfile&file=/dir_04/he2004_0266.pdf
/index.php?option=com_iwpfile&file=/dir_04/he2004_0265.pdf
/index.php?option=com_iwpfile&file=/dir_04/he2004_0264.pdf
/index.php?option=com_iwpfile&file=/dir_04/he2004_0263.pdf
Pages
« first
‹ previous
…
6086
6087
6088
6089
6090
6091
6092
6093
6094
…
next ›
last »
Log in to access this content.
Username
*
Password
*
Remember me
Not a subscriber?
Sign up for 30 days free access
to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.